HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing

Angélique Bellemare-Pelletier, Jessy Tremblay, Sylvie Beaulieu, Mohamed Rachid Boulassel, Jean Pierre Routy, Bernard Massie, Réjean Lapointe, Jacques Thibodeau

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Through the regulation of human leukocyte antigen (HLA)-DM (DM) in B cells, HLA-DO (DO) modulates positively or negatively the presentation of specific peptides. Transduction of DO into human blood monocyte-derived dendritic cells (MoDC) has been proposed as a mean of modifying the peptide repertoire of major histocompatibility complex class II molecules. However, maturation of DC induced by inflammatory stimuli or possibly the adenoviral vector itself triggers acidification of vesicles and shuts down transcription of the class II trans-activator gene as well as de novo biosynthesis of class II-related molecules and DM activity. In these conditions, it is unclear that transduced DO could alter the peptide repertoire. Our Western blot and reverse transcriptase-polymerase chain reaction analyses revealed that human DC derived from blood monocytes express small amounts of DOα. Transduction of DOβ alone resulted in the accumulation of a small pool of DO in DM + CD63+ vesicles and at the plasma membrane of mature DC. The cell-surface increase in class II-associated invariant chain peptide (CLIP)/class II complexes is in line with an inhibitory role of DO on DM. Cotransduction of DOα and DOβ only slightly increased CLIP and DO levels at the cell surface. Together with the fact that a large fraction of transduced DO remains in the endoplasmic reticulum, this suggests that DM is limiting in these conditions. DO expression did not affect a mixed lymphocyte reaction but reduced presentation of the exogenous gp100 antigen to a specific T cell clone. These results show that transduced DO modulates antigen presentation in human mature MoDC, evoking the possible use of this chaperone for immunotherapy.

Original languageEnglish
Pages (from-to)95-105
Number of pages11
JournalJournal of Leukocyte Biology
Volume78
Issue number1
DOIs
Publication statusPublished - Jul 2005

Fingerprint

Histocompatibility Antigens Class II
Antigen Presentation
HLA Antigens
Dendritic Cells
Monocytes
Peptides
Mixed Lymphocyte Culture Test
Trans-Activators
Major Histocompatibility Complex
Reverse Transcriptase Polymerase Chain Reaction
Endoplasmic Reticulum
Immunotherapy
B-Lymphocytes
Clone Cells
Western Blotting
Cell Membrane
T-Lymphocytes
Antigens
Genes
invariant chain

Keywords

  • CLIP
  • HLA-DM
  • HLA-DR
  • Invariant chain
  • MHC

ASJC Scopus subject areas

  • Cell Biology

Cite this

Bellemare-Pelletier, A., Tremblay, J., Beaulieu, S., Boulassel, M. R., Routy, J. P., Massie, B., ... Thibodeau, J. (2005). HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing. Journal of Leukocyte Biology, 78(1), 95-105. https://doi.org/10.1189/jlb.0105020

HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing. / Bellemare-Pelletier, Angélique; Tremblay, Jessy; Beaulieu, Sylvie; Boulassel, Mohamed Rachid; Routy, Jean Pierre; Massie, Bernard; Lapointe, Réjean; Thibodeau, Jacques.

In: Journal of Leukocyte Biology, Vol. 78, No. 1, 07.2005, p. 95-105.

Research output: Contribution to journalArticle

Bellemare-Pelletier, A, Tremblay, J, Beaulieu, S, Boulassel, MR, Routy, JP, Massie, B, Lapointe, R & Thibodeau, J 2005, 'HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing', Journal of Leukocyte Biology, vol. 78, no. 1, pp. 95-105. https://doi.org/10.1189/jlb.0105020
Bellemare-Pelletier, Angélique ; Tremblay, Jessy ; Beaulieu, Sylvie ; Boulassel, Mohamed Rachid ; Routy, Jean Pierre ; Massie, Bernard ; Lapointe, Réjean ; Thibodeau, Jacques. / HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing. In: Journal of Leukocyte Biology. 2005 ; Vol. 78, No. 1. pp. 95-105.
@article{517b5fd11cf34582a57e041e590b2a96,
title = "HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing",
abstract = "Through the regulation of human leukocyte antigen (HLA)-DM (DM) in B cells, HLA-DO (DO) modulates positively or negatively the presentation of specific peptides. Transduction of DO into human blood monocyte-derived dendritic cells (MoDC) has been proposed as a mean of modifying the peptide repertoire of major histocompatibility complex class II molecules. However, maturation of DC induced by inflammatory stimuli or possibly the adenoviral vector itself triggers acidification of vesicles and shuts down transcription of the class II trans-activator gene as well as de novo biosynthesis of class II-related molecules and DM activity. In these conditions, it is unclear that transduced DO could alter the peptide repertoire. Our Western blot and reverse transcriptase-polymerase chain reaction analyses revealed that human DC derived from blood monocytes express small amounts of DOα. Transduction of DOβ alone resulted in the accumulation of a small pool of DO in DM + CD63+ vesicles and at the plasma membrane of mature DC. The cell-surface increase in class II-associated invariant chain peptide (CLIP)/class II complexes is in line with an inhibitory role of DO on DM. Cotransduction of DOα and DOβ only slightly increased CLIP and DO levels at the cell surface. Together with the fact that a large fraction of transduced DO remains in the endoplasmic reticulum, this suggests that DM is limiting in these conditions. DO expression did not affect a mixed lymphocyte reaction but reduced presentation of the exogenous gp100 antigen to a specific T cell clone. These results show that transduced DO modulates antigen presentation in human mature MoDC, evoking the possible use of this chaperone for immunotherapy.",
keywords = "CLIP, HLA-DM, HLA-DR, Invariant chain, MHC",
author = "Ang{\'e}lique Bellemare-Pelletier and Jessy Tremblay and Sylvie Beaulieu and Boulassel, {Mohamed Rachid} and Routy, {Jean Pierre} and Bernard Massie and R{\'e}jean Lapointe and Jacques Thibodeau",
year = "2005",
month = "7",
doi = "10.1189/jlb.0105020",
language = "English",
volume = "78",
pages = "95--105",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "1",

}

TY - JOUR

T1 - HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing

AU - Bellemare-Pelletier, Angélique

AU - Tremblay, Jessy

AU - Beaulieu, Sylvie

AU - Boulassel, Mohamed Rachid

AU - Routy, Jean Pierre

AU - Massie, Bernard

AU - Lapointe, Réjean

AU - Thibodeau, Jacques

PY - 2005/7

Y1 - 2005/7

N2 - Through the regulation of human leukocyte antigen (HLA)-DM (DM) in B cells, HLA-DO (DO) modulates positively or negatively the presentation of specific peptides. Transduction of DO into human blood monocyte-derived dendritic cells (MoDC) has been proposed as a mean of modifying the peptide repertoire of major histocompatibility complex class II molecules. However, maturation of DC induced by inflammatory stimuli or possibly the adenoviral vector itself triggers acidification of vesicles and shuts down transcription of the class II trans-activator gene as well as de novo biosynthesis of class II-related molecules and DM activity. In these conditions, it is unclear that transduced DO could alter the peptide repertoire. Our Western blot and reverse transcriptase-polymerase chain reaction analyses revealed that human DC derived from blood monocytes express small amounts of DOα. Transduction of DOβ alone resulted in the accumulation of a small pool of DO in DM + CD63+ vesicles and at the plasma membrane of mature DC. The cell-surface increase in class II-associated invariant chain peptide (CLIP)/class II complexes is in line with an inhibitory role of DO on DM. Cotransduction of DOα and DOβ only slightly increased CLIP and DO levels at the cell surface. Together with the fact that a large fraction of transduced DO remains in the endoplasmic reticulum, this suggests that DM is limiting in these conditions. DO expression did not affect a mixed lymphocyte reaction but reduced presentation of the exogenous gp100 antigen to a specific T cell clone. These results show that transduced DO modulates antigen presentation in human mature MoDC, evoking the possible use of this chaperone for immunotherapy.

AB - Through the regulation of human leukocyte antigen (HLA)-DM (DM) in B cells, HLA-DO (DO) modulates positively or negatively the presentation of specific peptides. Transduction of DO into human blood monocyte-derived dendritic cells (MoDC) has been proposed as a mean of modifying the peptide repertoire of major histocompatibility complex class II molecules. However, maturation of DC induced by inflammatory stimuli or possibly the adenoviral vector itself triggers acidification of vesicles and shuts down transcription of the class II trans-activator gene as well as de novo biosynthesis of class II-related molecules and DM activity. In these conditions, it is unclear that transduced DO could alter the peptide repertoire. Our Western blot and reverse transcriptase-polymerase chain reaction analyses revealed that human DC derived from blood monocytes express small amounts of DOα. Transduction of DOβ alone resulted in the accumulation of a small pool of DO in DM + CD63+ vesicles and at the plasma membrane of mature DC. The cell-surface increase in class II-associated invariant chain peptide (CLIP)/class II complexes is in line with an inhibitory role of DO on DM. Cotransduction of DOα and DOβ only slightly increased CLIP and DO levels at the cell surface. Together with the fact that a large fraction of transduced DO remains in the endoplasmic reticulum, this suggests that DM is limiting in these conditions. DO expression did not affect a mixed lymphocyte reaction but reduced presentation of the exogenous gp100 antigen to a specific T cell clone. These results show that transduced DO modulates antigen presentation in human mature MoDC, evoking the possible use of this chaperone for immunotherapy.

KW - CLIP

KW - HLA-DM

KW - HLA-DR

KW - Invariant chain

KW - MHC

UR - http://www.scopus.com/inward/record.url?scp=22144474382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144474382&partnerID=8YFLogxK

U2 - 10.1189/jlb.0105020

DO - 10.1189/jlb.0105020

M3 - Article

VL - 78

SP - 95

EP - 105

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 1

ER -